secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001140361-23-022312
Event type: debt
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics amends Hayfin credit agreement, cuts rate by 1%, extends $25M delayed draw loan
--------------------------------------------------------------------------------

- Interest rate reduced 1% to SOFR + 8.50%; up to 2.50% interest may be paid in kind.
- New 50% waiver of prepayment fee on acquisition or strategic transactions within 24 months.
- Delayed draw term loan of $25M extended from June 30, 2023 to December 31, 2023.
- Issued warrants for 2,391,244 shares at $3.2619 per share, expiring May 1, 2030.
- Total debt level unchanged; company cites strengthened financial outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123022312/0001140361-23-022312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036123022312/brhc20052223_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-022312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer